How paraproteins can affect laboratory assays: spurious results and biological effects

References

• Kyle RA, Therneau TM, Rajkumar SV, et al Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354: 1362–1369.
   PubMed Web of Science ®Google Scholar
• Smogorzewska A, Flood JG, Long WH, et al Paraprotein interference in automated chemistry analyzers. Clin Chem 2004; 50: 1691–1693.
   PubMed Web of Science ®Google Scholar
• Berth M, Delanghe J. Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature. Acta Clin Belg 2004; 59: 263–273.
   PubMed Web of Science ®Google Scholar
• Hullin DA. An IgM paraprotein causing a falsely low result in an enzymatic assay for acetaminophen. Clin Chem 1999; 45: 155–157.
   PubMed Web of Science ®Google Scholar
• Sonnenblick M, Eylath U, Brisk R, et al Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma. Clin Chem 1986; 32: 1537–1539.
   PubMedGoogle Scholar
• Hawkins RCW. Pseudohyperphosphataemia in multiple myeloma. Ann Clin Biochem 1991; 28: 226.
   PubMed Web of Science ®Google Scholar
• Poupon-Fleuret C, Chapuis-Cellier C. Monoclonal immunoglobulin interferences in measurement of serum inorganic phosphate with a new modified reagent. Clin Chem 1996; 42: 1298–1300.
   PubMed Web of Science ®Google Scholar
• Bakker AJ, Mucke M. Gammopathy interference in clinical chemistry assays: Mechanisms, detection and prevention. Clin Chem Lab Med 2007; 45: 1240–1243.
   PubMed Web of Science ®Google Scholar
• Kunz W, Henle J, Ninham BW. ‘Zur Lehre von der Wirkung der Salze’ (about the science of the effect of salts): Franz Hofmeister's historical papers. Curr Opin Colloid Interface Sci 2004; 9: 19–37.
   Web of Science ®Google Scholar
• Zhang Y, Cremer PS. Interactions between macromolecules and ions: the Hofmeister series. Curr Opin Chem Biol 2006; 10: 658–663.
   PubMed Web of Science ®Google Scholar
• Granouillet R, Rascle F, Bonneau C, et al Evidence of temperature-dependent interference in an immunonephelometric assay by monoclonal IgM. Clin Chem 1999; 45: 2039–2040.
   PubMed Web of Science ®Google Scholar
• Reed RG. Interference by an IgM paraprotein in the bromcresol green method for determination of serum albumin. Clin Chem 1987; 33: 1075–1076.
   PubMed Web of Science ®Google Scholar
• Datta P, Graham GA, Schoen I. Interference by IgG paraproteins in the Jaffe method for creatinine determination. Am J Clin Pathol 1986; 85: 463.
   PubMed Web of Science ®Google Scholar
• Luzzi VI, Scott MG, Gronowski AM. Negative thyrotropin assay interference associated with an IgG{kappa} paraprotein. Clin Chem 2003; 49: 709–710.
   PubMed Web of Science ®Google Scholar
• Gallou G, Legras B, Ruelland A, et al Problems of C-reactive protein determination in patients with monoclonal immunoglobulins. Clin Chem 1993; 39: 918.
   PubMed Web of Science ®Google Scholar
• Chan KM, Ladenson JH. Sample viscosity can be a source of analytical error when discrete sampler-dilutors are used. Clin Chem 1981; 27: 1896–1898.
   PubMed Web of Science ®Google Scholar
• Jaynes P, Witte D, Simpson C, et al Interference by some monoclonal IgMs in discrete serum creatinine analysis. 34th National Meeting of the American Association for Clinical Chemistry, Anaheim, California. Clin Chem 1982; 28: 1532–1702.
   Google Scholar
• Singer GG, Brenner BM. Fluid and electrolyte disturbances. In: Braunwald E, editor. Harrison's Principles of Internal Medicine. 15th ed. New York: McGraw-Hill, 2001.
   Google Scholar
• Ladenson JH, Apple FS, Aguanno JJ, et al Sodium measurements in multiple myeloma: two techniques compared. Clin Chem 1982; 28: 2383–2386.
   PubMed Web of Science ®Google Scholar
• Waugh WH. Utility of expressing serum sodium per unit of water in assessing hyponatremia. Metabolism 1969; 18: 706–712.
   PubMed Web of Science ®Google Scholar
• Tom P, Lars H, Anna Maija T, et al Phosphate binding by a myeloma protein. Acta Med Scand 1987; 222: 89–91.
   PubMedGoogle Scholar
• José MM, Marshall RP, Joseph RT, et al Hyperphosphatemia in multiple myeloma due to a phosphate-binding immunoglobulin. Cancer 1991; 68: 1092–1094.
   PubMedGoogle Scholar
• Pearce CJ, Hine TJ, Peek K. Hypercalcaemia due to calcium binding by a polymeric IgA kappa-paraprotein. Ann Clin Biochem 1991; 28: 229–234.
   PubMedGoogle Scholar
• Lindgarde F, Zettervall O. Hypercalcemia and normal ionized serum calcium in a case of myelomatosis. Ann Intern Med 1973; 78: 396–399.
   PubMedGoogle Scholar
• Jaffe JP, Mosher DF. Calcium binding by a myeloma protein. Am J Med 1979; 67: 343–346.
   PubMed Web of Science ®Google Scholar
• Baker BL, Hultquist DE. A copper-binding immunoglobulin from a myeloma patient. Purification, identification, and physical characterization. J Biol Chem 1978; 253: 1195–1200.
   PubMed Web of Science ®Google Scholar
• Remaley AT, Wilding P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection. Clin Chem 1989; 35: 2261–2270.
   PubMed Web of Science ®Google Scholar
• Nair S, Sachan P, Hertan H, et al Metastatic multiple myeloma with hyperamylasaemia and hyperlipasaemia. Postgrad Med J 1998; 74: 621–623.
   PubMed Web of Science ®Google Scholar
• Backer ET, Harff GA, Beyer C. A patient with an IgG paraprotein and complexes of lactate dehydrogenase and IgG in the serum. Clin Chem 1987; 33: 1937–1938.
   PubMedGoogle Scholar
• Hata H, Matsuzaki H, Tanaka K, et al Ectopic production of salivary-type amylase by a IgA-lambda-type multiple myeloma. Cancer 1988; 62: 1511–1515.
   PubMed Web of Science ®Google Scholar
• Ross CM, Devgun MS, Gunn IR. Hyperamylasaemia and multiple myeloma. Ann Clin Biochem 2002; 39: 616–620.
   PubMed Web of Science ®Google Scholar
• Khant M, Florkowski CM, Livesey JH, et al Insulin autoimmune syndrome due to IgG kappa paraprotein. Pathology 2004; 36: 86–87.
   PubMed Web of Science ®Google Scholar
• Halsall DJ, Mangi M, Soos M, et al Clinical case seminar: Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma. J Clin Endocrinol Metab 2007; 92: 2013–2016.
   PubMed Web of Science ®Google Scholar
• Rhie FH, Ganda OP, Bern MM. Insulin resistance and monoclonal gammopathy. Metabolism 1981; 30: 41–45.
   PubMedGoogle Scholar
• Cissewski K, Faix JD, Reinwein D, et al Factitious hyperthyroxinemia due to a monoclonal IgA in a case of multiple myeloma. Clin Chem 1993; 39: 1739–1742.
   PubMed Web of Science ®Google Scholar
• Chee L, Spearing RL, Morris CM, et al Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipient. Bone Marrow Transplant 2005; 35: 1213–1214.
   PubMedGoogle Scholar
• Burnside NJ, Alberta L, Robinson-Bostom L, et al Type III hyperlipoproteinemia with xanthomas and multiple myeloma. J Am Acad Dermatol 2005; 53: S281–S284.
   Google Scholar
• Nozaki S, Ito Y, Nakagawa T, et al Autoimmune hyperlipidemia with inhibitory monoclonal antibodies against low density lipoprotein binding to fibroblasts in a case with multiple myeloma. Intern Med 1997; 36: 920–925.
   PubMedGoogle Scholar
• Feingold KR, Castro GR, Ishikawa Y, et al Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia. J Clin Invest 1989; 83: 796–803.
   PubMedGoogle Scholar
• Kilgore LL, Patterson BW, Parenti DM, et al Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma: Characterization of this immunoglobulin. J Clin Invest 1985; 76: 225–232.
   PubMedGoogle Scholar
• Wilson DE, Flowers CM, Hershgold EJ, et al Multiple myeloma, cryoglobulinemia and xanthomatosis. Distinct clinical and biochemical syndromes in two patients. Am J Med 1975; 59: 721–729.
   PubMedGoogle Scholar
• Murray T, Long W, Narins RG. Multiple myeloma and the anion gap. N Engl J Med 1975; 292: 574–575.
   PubMed Web of Science ®Google Scholar
• De Troyer A, Stolarczyk A, De Beyl DZ, et al Value of anion gap determination in multiple myeloma. N Engl J Med 1977; 296: 858–860.
   PubMedGoogle Scholar